does tirzepatide cause less side effects than semaglutide vs Tirzepatide: Which Is Better for Weight Loss? Comparative safety and side effects

N Engl J Med 380(24):22952306 Kristensen SL, Rrth R, Jhund PS, Docherty KF, Sattar N, Preiss D et al (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

promising but still investigational

One RCT demonstrated improved cardiometabolic risk markers in older adults losing 8% body weight from baseline with energy-restriction and exercise (vs

Entiende por qu el dficit calrico y el entrenamiento siguen siendo la base, mientras el suplemento acta, en el mejor de los casos, como apoyo puntual

New England Journal of Medicine, 384 (11), 989-1002